Biopure is falling more than 14 percent to $2.60 after the company filed a prospectus supplement under its shelf registration statement for the sale of up to 5.5 million class A common shares at a ...

The biotech company takes in $10.5 million from a stock offering as it fights to stay alive.

BioPure wouldn't talk about the issue with the Globe, distancing itself by saying Richman hadn't worked there for years. But the company is not exactly free and clear of questionable judgment ...

Biopure Corp., a Cambridge company that’s been reduced over the past year to a shell of assets and unrealized biotech potential, has gone belly up. The 25-year-old firm, known for its synthetic ...

LONDON (MarketWatch) -- Drug company Biopure Corp. said its fiscal fourth-quarter net loss narrowed to $6.3 million, or 13 cents a share, from $8.2 million, or 34 cents a share a year ago. Revenue ...

said Wednesday that it expects to run out of money in eight weeks, adding that it must raise $19 million to keep operating through October. The announcement is the latest in a series of regulatory ...

KINGSPORT, Tenn. (WJHL) – Stronger together. A Tri-Cities business giving back in the midst of COVID-19. bioPURE, a Johnson City-based disinfectant company treated Second Harvest Food Bank in ...

A former Biopure Corp. executive agreed to pay a $150,000 civil penalty to settle allegations that he misled investors about the Massachusetts biotech company's prospects for obtaining regulatory ...

BOSTON -- The Securities and Exchange Commission filed civil fraud charges against Biopure Corp. and several current and former executives, alleging they raised more than $35 million from ...

BOSTON — A former executive of Biopure Corp. pleaded guilty Wednesday to an obstruction of justice charge for pretending he had terminal cancer and admitted he had impersonated his own doctor to ...